{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T03:15:53Z","timestamp":1790046953557,"version":"4.0.1"},"reference-count":258,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100020269","name":"Asian Universities Alliance","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.clinbiochem.2024.110776","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T05:29:21Z","timestamp":1717133361000},"page":"110776","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Exploring novel protein-based biomarkers for advancing breast cancer diagnosis: A review"],"prefix":"10.1016","volume":"129","author":[{"given":"Christina Jane","family":"Vellan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumadee","family":"De Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur Aishah","family":"Mohd Taib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Galhena","family":"Prasanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime Jacqueline","family":"Jayapalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b0005","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b0010","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3322\/caac.21446","article-title":"Cancer screening in the united states, 2018: a review of current american cancer society guidelines and current issues in cancer screening","volume":"68","author":"Smith","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3322\/caac.21550","article-title":"A blueprint for cancer screening and early detection: Advancing screening\u2019s contribution to cancer control","volume":"69","author":"Wender","year":"2019","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110776_b0020","first-page":"256","article-title":"Cancer biomarker discovery and validation","volume":"4","author":"Goossens","year":"2015","journal-title":"Transl. Cancer Res."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110776_b0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nrc.2016.153","article-title":"Precision diagnostics: moving towards protein biomarker signatures of clinical utility in cancer","volume":"17","author":"Borrebaeck","year":"2017","journal-title":"Nature Reviews in Cancer."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110776_b0030","doi-asserted-by":"crossref","first-page":"24","DOI":"10.21037\/cco.2017.06.32","article-title":"Epidemiology of pancreatic adenocarcinoma","volume":"6","author":"Simoes","year":"2017","journal-title":"Chin. Clin. Oncol."},{"issue":"19","key":"10.1016\/j.clinbiochem.2024.110776_b0035","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.3390\/ijms20194781","article-title":"The need for multi-omics biomarker signatures in precision medicine","volume":"20","author":"Olivier","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1021\/acs.chemrestox.3c00223","article-title":"Recent contributions of mass spectrometry-based \u201comics\u201d in the studies of breast cancer","volume":"37","author":"Banerjee","year":"2024","journal-title":"Chem. Res. Toxicol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b0045","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1002\/mco2.315","article-title":"Applications of multi-omics analysis in human diseases","volume":"4","author":"Chen","year":"2023","journal-title":"MedComm"},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b0050","doi-asserted-by":"crossref","DOI":"10.1002\/prca.202300016","article-title":"Realm of proteomics in breast cancer management and drug repurposing to alleviate intricacies of treatment","volume":"17","author":"Behera","year":"2023","journal-title":"Proteomics \u2013 Clinical Applications."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b0055","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s12282-018-00941-4","article-title":"Breast cancer incidence, mortality and mortality-to-incidence ratio (MIR) are associated with human development, 1990\u20132016: evidence from global burden of disease study 2016","volume":"26","author":"Sharma","year":"2019","journal-title":"Breast Cancer"},{"issue":"17","key":"10.1016\/j.clinbiochem.2024.110776_b0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174287","article-title":"Breast cancer - epidemiology, risk factors, classification, prognostic markers, and current treatment strategies - an updated review","volume":"13","author":"\u0141ukasiewicz","year":"2021","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110776_b0065","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110776_b0070","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMp0708307","article-title":"\u201cWesternizing\u201d women's risks? Breast cancer in lower-income countries","volume":"358","author":"Porter","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.clinbiochem.2024.110776_b0075","doi-asserted-by":"crossref","DOI":"10.3390\/nu15092057","article-title":"The risk of breast cancer between Western and Mediterranean dietary patterns","volume":"15","author":"Tsai","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.clinbiochem.2024.110776_b0080","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.canep.2018.12.012","article-title":"Healthy lifestyle and breast cancer risk: a case-control study in Morocco","volume":"58","author":"Khalis","year":"2019","journal-title":"Cancer Epidemiol."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0085","first-page":"151","article-title":"Epidemiological characteristics of and risk factors for breast cancer in the world","volume":"11","author":"Momenimovahed","year":"2019","journal-title":"Breast Cancer"},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b0090","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s11684-009-0080-z","article-title":"Meta-analysis of the risk factors of breast cancer concerning reproductive factors and oral contraceptive use","volume":"3","author":"Dai","year":"2009","journal-title":"Front. Med. China"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0095","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bjc.6602302","article-title":"Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects","volume":"92","author":"Albrektsen","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0100","doi-asserted-by":"crossref","first-page":"4255","DOI":"10.1038\/s41467-018-06748-3","article-title":"Pregnancy duration and breast cancer risk","volume":"9","author":"Husby","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110776_b0105","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1158\/1055-9965.EPI-17-0837","article-title":"Family history and risk of second primary breast cancer after in situ breast carcinoma","volume":"27","author":"Baglia","year":"2018","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b0110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3961\/jpmph.17.152","article-title":"Risk reduction of breast cancer by childbirth, breastfeeding, and their interaction in Korean women: heterogeneous effects across menopausal status, hormone receptor status, and pathological subtypes","volume":"50","author":"Jeong","year":"2017","journal-title":"J. Prev. Med. Public Health"},{"issue":"21","key":"10.1016\/j.clinbiochem.2024.110776_b0115","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1002\/cncr.33138","article-title":"Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women","volume":"126","author":"Kim","year":"2020","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0120","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13058-018-0967-1","article-title":"Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape","volume":"20","author":"Kader","year":"2018","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0125","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/s41598-020-58134-z","article-title":"Secondary cancer risk after radiation therapy for breast cancer with different radiotherapy techniques","volume":"10","author":"Zhang","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110776_b0130","doi-asserted-by":"crossref","first-page":"e1004188","DOI":"10.1371\/journal.pmed.1004188","article-title":"Combined and progestagen-only hormonal contraceptives and breast cancer risk: a UK nested case\u2013control study and meta-analysis","volume":"20","author":"Fitzpatrick","year":"2023","journal-title":"PLoS Med."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0135","article-title":"Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases","volume":"371","author":"Vinogradova","year":"2020","journal-title":"BMJ Cancer."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13053-021-00199-6","article-title":"Can harmful lifestyle, obesity and weight changes increase the risk of breast cancer in BRCA 1 and BRCA 2 mutation carriers? a mini review","volume":"19","author":"Daniele","year":"2021","journal-title":"Hereditary Cancer in Clinical Practice."},{"issue":"26","key":"10.1016\/j.clinbiochem.2024.110776_b0145","doi-asserted-by":"crossref","first-page":"e11220","DOI":"10.1097\/MD.0000000000011220","article-title":"Body mass index and prognosis of breast cancer: an analysis by menstruation status when breast cancer diagnosis","volume":"97","author":"Sun","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/j.clinbiochem.2024.110776_b0150","article-title":"Consumption of ultra-processed foods and cancer risk: Results from NutriNet-Sant\u00e9 prospective cohort","volume":"360","author":"Fiolet","year":"2018","journal-title":"BMJ Cancer."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b0155","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/em.22155","article-title":"Prenatal diethylstilbestrol exposure and cancer risk in women","volume":"60","author":"Troisi","year":"2019","journal-title":"Environ. Mol. Mutagen."},{"issue":"23","key":"10.1016\/j.clinbiochem.2024.110776_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21239139","article-title":"Exposure to endocrine disrupting chemicals and risk of breast cancer","volume":"21","author":"Eve","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b0165","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000509025","article-title":"Histology of luminal breast cancer","volume":"15","author":"Erber","year":"2020","journal-title":"Breast Care."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0170","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/path.2407","article-title":"Refinement of breast cancer classification by molecular characterization of histological special types","volume":"216","author":"Weigelt","year":"2008","journal-title":"J Pathol."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0175","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1186\/1471-2407-13-558","article-title":"St Gallen molecular subtypes in primary breast cancer and matched lymph node metastases-aspects on distribution and prognosis for patients with luminal A tumours: results from a prospective randomised trial","volume":"13","author":"Falck","year":"2013","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0180","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13058-023-01747-9","article-title":"Molecular subtypes of breast cancer predicting clinical benefits of radiotherapy after breast-conserving surgery: a propensity-score-matched cohort study","volume":"25","author":"Hung","year":"2023","journal-title":"Breast Cancer Res."},{"issue":"6797","key":"10.1016\/j.clinbiochem.2024.110776_b0185","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110776_b0190","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4274\/ejbh.galenos.2021.2021-4-3","article-title":"American joint committee on cancer's staging system for breast cancer, eighth edition: summary for clinicians","volume":"17","author":"Zhu","year":"2021","journal-title":"European Journal of Breast Health."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0195","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1001\/jamaoncol.2017.4298","article-title":"Validation study of the American Joint Committee on cancer eighth edition prognostic stage compared with the anatomic stage in breast cancer","volume":"4","author":"Weiss","year":"2018","journal-title":"JAMA Oncology"},{"issue":"11","key":"10.1016\/j.clinbiochem.2024.110776_b0200","doi-asserted-by":"crossref","first-page":"4475","DOI":"10.1245\/s10434-020-08608-1","article-title":"Molecular biological features of Nottingham histological grade 3 breast cancers","volume":"27","author":"Takahashi","year":"2020","journal-title":"Ann. Surg. Oncol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b0205","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1111\/tbj.13859","article-title":"Multigene testing in breast cancer: What have we learned from the 21-gene recurrence score assay?","volume":"26","author":"Turashvili","year":"2020","journal-title":"Breast J."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0210","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6004\/jnccn.2021.0001","article-title":"Genetic\/familial high-risk assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology","volume":"19","author":"Daly","year":"2021","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1148\/radiol.2019180760","article-title":"Digital breast tomosynthesis: concepts and clinical practice","volume":"292","author":"Chong","year":"2019","journal-title":"Radiology"},{"key":"10.1016\/j.clinbiochem.2024.110776_b0220","unstructured":"NICE. National Institute for Health and Care Excellence: Guidelines. Early and locally advanced breast cancer: Diagnosis and management. London: National Institute for Health and Care Excellence (NICE) Copyright \u00a9 NICE 2018.; 2018."},{"issue":"8","key":"10.1016\/j.clinbiochem.2024.110776_b0225","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1200\/JCO.2001.19.8.2254","article-title":"Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma","volume":"19","author":"Morrow","year":"2001","journal-title":"J. Clin. Oncol."},{"issue":"16","key":"10.1016\/j.clinbiochem.2024.110776_b0230","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","article-title":"Breast cancer molecular subtypes respond differently to preoperative chemotherapy","volume":"11","author":"Rouzier","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0235","article-title":"Neoadjuvant therapy for breast cancer as a model for translational research","volume":"13","author":"Selli","year":"2019","journal-title":"Breast Cancer"},{"issue":"10","key":"10.1016\/j.clinbiochem.2024.110776_b0240","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s12032-022-01749-1","article-title":"Molecular perspective on targeted therapy in breast cancer: a review of current status","volume":"39","author":"Demir Cetinkaya","year":"2022","journal-title":"Med. Oncol."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0245","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1200\/EDBK_350358","article-title":"Personalizing adjuvant endocrine therapy for early-stage hormone receptor\u2013positive breast cancer","volume":"42","author":"Pistilli","year":"2022","journal-title":"Am. Soc. Clin. Oncol. Educ. Book"},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b0250","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1200\/JCO.20.02510","article-title":"Selection of optimal adjuvant chemotherapy and targeted therapy for early breast cancer: ASCO guideline update","volume":"39","author":"Denduluri","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0255","first-page":"299","article-title":"Breast cancer adjuvant radiotherapy in BRCA1\/2, TP53, ATM genes mutations: are there solved issues?","volume":"13","author":"Lazzari","year":"2021","journal-title":"Breast Cancer (dove Med Press)."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0260","doi-asserted-by":"crossref","first-page":"4786819","DOI":"10.1155\/2018\/4786819","article-title":"The evolution of radiation therapy in metastatic breast cancer: From local therapy to systemic agent","volume":"2018","author":"Jutzy","year":"2018","journal-title":"International Journal of Breast Cancer."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b0265","doi-asserted-by":"crossref","first-page":"162","DOI":"10.5152\/ejbh.2017.3635","article-title":"Reliable biomarkers to identify new and recurrent cancer","volume":"13","author":"Sauter","year":"2017","journal-title":"European Journal of Breast Health."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0270","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1559-0275-10-13","article-title":"Translation of proteomic biomarkers into FDA approved cancer diagnostics: issues and challenges","volume":"10","author":"F\u00fcz\u00e9ry","year":"2013","journal-title":"Clin. Proteomics"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0275","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40364-022-00403-2","article-title":"Detection of circulating tumor cells: opportunities and challenges","volume":"10","author":"Ju","year":"2022","journal-title":"Biomarker Res."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b0280","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/1758834010378414","article-title":"Circulating tumour cells: their utility in cancer management and predicting outcomes","volume":"2","author":"Krebs","year":"2010","journal-title":"Therapeutic Advances in Medical Oncology."},{"issue":"38","key":"10.1016\/j.clinbiochem.2024.110776_b0285","doi-asserted-by":"crossref","first-page":"62754","DOI":"10.18632\/oncotarget.11191","article-title":"Technical challenges in the isolation and analysis of circulating tumor cells","volume":"7","author":"van der Toom","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.clinbiochem.2024.110776_b0290","article-title":"Breast cancer therapeutics and biomarkers: past, present, and future approaches","volume":"15","author":"Schick","year":"2021","journal-title":"Breast Cancer"},{"issue":"12","key":"10.1016\/j.clinbiochem.2024.110776_b0295","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.5858\/arpa.2019-0205-RA","article-title":"Breast cancer biomarkers: Challenges in routine estrogen receptor, progesterone receptor, and HER2\/neu evaluation","volume":"143","author":"Jorns","year":"2019","journal-title":"Arch. Pathol. Lab. Med."},{"issue":"8","key":"10.1016\/j.clinbiochem.2024.110776_b0300","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/s41416-020-1009-1","article-title":"The significance of highlighting the oestrogen receptor low category in breast cancer","volume":"123","author":"Poon","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0305","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13058-016-0779-0","article-title":"Accurate prediction of response to endocrine therapy in breast cancer patients: current and future biomarkers","volume":"18","author":"Selli","year":"2016","journal-title":"Breast Cancer Res."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b0310","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13051166","article-title":"Variability in breast cancer biomarker assessment and the effect on oncological treatment decisions: a nationwide 5-Year population-based study","volume":"13","author":"Acs","year":"2021","journal-title":"Cancers (Basel)."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0315","doi-asserted-by":"crossref","first-page":"T49","DOI":"10.1530\/JME-20-0104","article-title":"90 Years of progesterone: progesterone and progesterone receptors in breast cancer: past, present, future","volume":"65","author":"Horwitz","year":"2020","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0320","doi-asserted-by":"crossref","DOI":"10.1177\/1758835919888999","article-title":"The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3 trial","volume":"12","author":"Bravaccini","year":"2020","journal-title":"Therapeutic Advances in Medical Oncology."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0325","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2147\/DDDT.S336643","article-title":"The role of progesterone receptors in breast cancer","volume":"16","author":"Li","year":"2022","journal-title":"Drug Des. Devel. Ther."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b0330","article-title":"Hormone receptor (ER, PR, HER2\/neu) status and proliferation index marker (Ki-67) in breast cancers: their onco-pathological correlation, shortcomings and future trends","volume":"9","author":"Iqbal","year":"2016","journal-title":"Medical Journal of Dr DY Patil University."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b0335","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1309\/AJCPT41TCBUEVDQC","article-title":"Advantages and disadvantages of technologies for HER2 testing in breast cancer specimens","volume":"144","author":"Furrer","year":"2015","journal-title":"Am. J. Clin. Pathol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b0340","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/pin.12407","article-title":"The assessment of HER2 status in breast cancer: the past, the present, and the future","volume":"66","author":"Nitta","year":"2016","journal-title":"Pathol. Int."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0345","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13058-024-01779-9","article-title":"Prognostic impact of HER2 biomarker levels in trastuzumab-treated early HER2-positive breast cancer","volume":"26","author":"R\u00f6nnlund","year":"2024","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0350","doi-asserted-by":"crossref","first-page":"9863092","DOI":"10.1155\/2018\/9863092","article-title":"Clinicopathological and prognostic significance of cancer antigen 15\u20133 and carcinoembryonic antigen in breast cancer: a meta-analysis including 12,993 patients","volume":"2018","author":"Li","year":"2018","journal-title":"Dis Markers."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b0355","doi-asserted-by":"crossref","DOI":"10.2217\/bmt-2020-0015","article-title":"The utility of the tumor markers CA15.3, CEA, CA-125 and CA19.9 in metastatic breast cancer","volume":"9","author":"Gaughran","year":"2020","journal-title":"Breast Cancer Management"},{"issue":"23","key":"10.1016\/j.clinbiochem.2024.110776_b0360","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1016\/j.cca.2010.08.039","article-title":"CA 15\u20133: Uses and limitation as a biomarker for breast cancer","volume":"411","author":"Duffy","year":"2010","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b0365","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1177\/172460080001500412","article-title":"The prognostic value of the tumor marker CA 15\u20133 at initial diagnosis of patients with breast cancer","volume":"15","author":"McLaughlin","year":"2000","journal-title":"Int. J. Biol. Markers"},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0370","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4048\/jbc.2023.26.e17","article-title":"Prognostic impact of elevation of cancer antigen 15\u20133 (CA15-3) in patients with early breast cancer with normal serum CA15-3 Level","volume":"26","author":"Ryu","year":"2023","journal-title":"J. Breast Cancer"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0375","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.jons.2017.01.001","article-title":"Tumor markers of breast cancer: new prospectives","volume":"3","author":"Kabel","year":"2017","journal-title":"Journal of Oncological Sciences."},{"issue":"7","key":"10.1016\/j.clinbiochem.2024.110776_b0380","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071721","article-title":"MUC1 (CA27.29) before and after chemotherapy and prognosis in high-risk early breast cancer patients","volume":"14","author":"Huebner","year":"2022","journal-title":"Cancers (basel)."},{"issue":"7","key":"10.1016\/j.clinbiochem.2024.110776_b0385","doi-asserted-by":"crossref","first-page":"e0133830","DOI":"10.1371\/journal.pone.0133830","article-title":"Elevated levels of serum tumor markers CEA and CA15-3 are prognostic parameters for different molecular subtypes of breast cancer","volume":"10","author":"Shao","year":"2015","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b0390","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s13277-011-0180-7","article-title":"Kinetics of CEA and CA15-3 correlate with treatment response in patients undergoing chemotherapy for metastatic breast cancer (MBC)","volume":"32","author":"Di Gioia","year":"2011","journal-title":"Tumour Biol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b0395","doi-asserted-by":"crossref","first-page":"86","DOI":"10.5493\/wjem.v2.i5.86","article-title":"Breast cancer and protein biomarkers","volume":"2","author":"Gam","year":"2012","journal-title":"World J Exp Med."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b0400","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1016\/j.clbc.2020.02.002","article-title":"Targeting PIK3CA alterations in hormone receptor-positive, human epidermal growth factor receptor-2\u2013negative advanced breast Cancer: new therapeutic approaches and practical considerations","volume":"20","author":"Schwartzberg","year":"2020","journal-title":"Clin. Breast Cancer"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0405","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/bcr3605","article-title":"PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data","volume":"16","author":"Zardavas","year":"2014","journal-title":"Breast Cancer Res."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0410","doi-asserted-by":"crossref","first-page":"21762","DOI":"10.1038\/s41598-020-78646-y","article-title":"Combination treatment with a PI3K\/Akt\/mTOR pathway inhibitor overcomes resistance to anti-HER2 therapy in PIK3CA-mutant HER2-positive breast cancer cells","volume":"10","author":"Fujimoto","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0415","first-page":"111","article-title":"PI3K mutations in breast cancer: prognostic and therapeutic implications","volume":"7","author":"Mukohara","year":"2015","journal-title":"Breast Cancer (dove Med Press)."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110776_b0420","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s10549-022-06637-w","article-title":"PIK3CA-mutations in breast cancer","volume":"196","author":"Reinhardt","year":"2022","journal-title":"Breast Cancer Research Treatment."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b0425","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.3390\/curroncol29050236","article-title":"PIK3CA mutation as potential poor prognostic marker in Asian female breast cancer patients who received adjuvant chemotherapy","volume":"29","author":"Cho","year":"2022","journal-title":"Curr. Oncol."},{"issue":"23","key":"10.1016\/j.clinbiochem.2024.110776_b0430","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.clinbiochem.2024.110776_b0435","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23073754","article-title":"BRCA1\/2 Serves as a biomarker for poor prognosis in breast carcinoma","volume":"23","author":"Jin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0440","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/s41416-018-0127-5","article-title":"BRCA1\/2 testing: Therapeutic implications for breast cancer management","volume":"119","author":"Tung","year":"2018","journal-title":"Br J Cancer."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110776_b0445","first-page":"357","article-title":"Psychosocial and ethical issues relating to genetic testing for BRCA1 and BRCA2 breast cancer susceptibility genes","volume":"2","author":"Winchester","year":"2006","journal-title":"Womens Health"},{"key":"10.1016\/j.clinbiochem.2024.110776_b0450","article-title":"FDA-approved and emerging next generation predictive biomarkers for immune checkpoint inhibitors in cancer patients","volume":"11","author":"Wang","year":"2021","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0455","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s40487-023-00224-9","article-title":"Immune checkpoint inhibitors in breast cancer: a narrative review","volume":"11","author":"Nunes Filho","year":"2023","journal-title":"Oncology Therapy."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0460","doi-asserted-by":"crossref","first-page":"1060308","DOI":"10.3389\/fimmu.2023.1060308","article-title":"PD-L1 expression as biomarker of efficacy of PD-1\/PD-L1 checkpoint inhibitors in metastatic triple negative breast cancer: a systematic review and meta-analysis","volume":"14","author":"Khan","year":"2023","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0465","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14020307","article-title":"Programmed death-ligand 1 (PD-L1) as immunotherapy biomarker in breast cancer","volume":"14","author":"N\u00fa\u00f1ez Abad","year":"2022","journal-title":"Cancers (Basel)."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0470","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102257","article-title":"Discordance of PD-L1 status between primary and metastatic breast cancer: a systematic review and meta-analysis","volume":"99","author":"Boman","year":"2021","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0475","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.617335","article-title":"Progress and challenges of predictive biomarkers for immune checkpoint blockade","volume":"11","author":"Lei","year":"2021","journal-title":"Front. Oncol."},{"issue":"7","key":"10.1016\/j.clinbiochem.2024.110776_b0480","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.annonc.2021.03.208","article-title":"How low can you go? PD-L1 expression as a biomarker in trials of cancer immunotherapy","volume":"32","author":"Fundytus A","year":"2021","journal-title":"Ann. Oncol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0485","first-page":"15","article-title":"PD-L1 testing by immunohistochemistry in immuno-oncology","volume":"23","author":"Vranic","year":"2023","journal-title":"Biomolecules and Biomedicine."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0490","series-title":"Translational Systems Medicine and Oral Disease","first-page":"93","article-title":"Proteomics","author":"Kaczor-Urbanowicz","year":"2020"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0495","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41392-020-0196-9","article-title":"Regulating tumor suppressor genes: post-translational modifications","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0500","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/cr.2013.151","article-title":"Protein post-translational modifications and regulation of pluripotency in human stem cells","volume":"24","author":"Wang","year":"2014","journal-title":"Cell Res."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0505","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/321370","article-title":"Proteomics in cancer biomarkers discovery: challenges and applications","volume":"2015","author":"Sallam","year":"2015","journal-title":"Dis. Markers"},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b0510","first-page":"546","article-title":"Proteomics: unraveling the complexity of heart disease and striving to change cardiology","volume":"3","author":"Van Eyk","year":"2001","journal-title":"Curr. Opin. Mol. Ther."},{"issue":"8","key":"10.1016\/j.clinbiochem.2024.110776_b0515","first-page":"1160","article-title":"Proteomics for cancer biomarker discovery","volume":"48","author":"Srinivas","year":"2002","journal-title":"Clin. Chem."},{"issue":"565","key":"10.1016\/j.clinbiochem.2024.110776_b0520","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.aaw3483","article-title":"Why geneticists stole cancer research even though cancer is primarily a signaling disease","volume":"12","author":"Yaffe","year":"2019","journal-title":"Sci. Signal."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0525","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12943-022-01526-8","article-title":"Proteomics technologies for cancer liquid biopsies","volume":"21","author":"Ding","year":"2022","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0530","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12014-022-09362-0","article-title":"Circulating proteins as predictive and prognostic biomarkers in breast cancer","volume":"19","author":"Veyssi\u00e8re","year":"2022","journal-title":"Clin. Proteomics"},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110776_b0535","doi-asserted-by":"crossref","first-page":"e003566","DOI":"10.1136\/jitc-2021-003566","article-title":"Role of mass spectrometry-based serum proteomics signatures in predicting clinical outcomes and toxicity in patients with cancer treated with immunotherapy","volume":"10","author":"Park","year":"2022","journal-title":"J. Immunother. Cancer"},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110776_b0540","doi-asserted-by":"crossref","first-page":"259","DOI":"10.21873\/cgp.20186","article-title":"Proteomics-based predictive model for the early detection of metastasis and recurrence in head and neck cancer","volume":"17","author":"Ribeiro","year":"2020","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.clinbiochem.2024.110776_b0545","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.747333","article-title":"Application of proteomics in cancer: recent trends and approaches for biomarkers discovery","volume":"8","author":"Kwon","year":"2021","journal-title":"Front. Med."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0550","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ctrv.2018.04.012","article-title":"Metabolomics in breast cancer: a decade in review","volume":"67","author":"McCartney","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0555","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jpba.2017.06.073","article-title":"The analytical process to search for metabolomics biomarkers","volume":"147","author":"Luque de Castro","year":"2018","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0560","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12014-020-09283-w","article-title":"Recent advances in mass spectrometry based clinical proteomics: applications to cancer research","volume":"17","author":"Macklin","year":"2020","journal-title":"Clin. Proteomics"},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b0565","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10585-018-9896-8","article-title":"Potential impact of invasive surgical procedures on primary tumor growth and metastasis","volume":"35","author":"Alieva","year":"2018","journal-title":"Clin. Exp. Metastasis"},{"issue":"16","key":"10.1016\/j.clinbiochem.2024.110776_b0570","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.7150\/jca.18457","article-title":"Breast cancer cell line classification and its relevance with breast tumor subtyping","volume":"8","author":"Dai","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.clinbiochem.2024.110776_b0575","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2019.00395","article-title":"Omics approaches to explore the breast cancer landscape","volume":"7","author":"Parsons","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0580","series-title":"Advances in mass spectrometry-based proteomics and its application in cancer research","first-page":"89","author":"Hardt","year":"2019"},{"issue":"8","key":"10.1016\/j.clinbiochem.2024.110776_b0585","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27082411","article-title":"Applications of tandem mass spectrometry (MS\/MS) in protein analysis for biomedical research","volume":"27","author":"Neagu","year":"2022","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0590","doi-asserted-by":"crossref","first-page":"16787","DOI":"10.1038\/s41598-021-96340-5","article-title":"Survival analysis in breast cancer using proteomic data from four independent datasets","volume":"11","author":"\u0150sz","year":"2021","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0595","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/mas.21347","article-title":"The application of quantification techniques in proteomics for biomedical research","volume":"32","author":"Rodr\u00edguez-Su\u00e1rez","year":"2013","journal-title":"Mass Spectrom Reviews."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0600","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12014-023-09424-x","article-title":"Mass spectrometry-based proteomics as an emerging tool in clinical laboratories","volume":"20","author":"Birhanu","year":"2023","journal-title":"Clin. Proteomics"},{"key":"10.1016\/j.clinbiochem.2024.110776_b0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2021.100165","article-title":"An introduction to advanced targeted acquisition methods","volume":"20","author":"van Bentum","year":"2021","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.clinbiochem.2024.110776_b0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2020.103780","article-title":"Identification of noninvasive diagnostic biomarkers for hepatocellular carcinoma by urinary proteomics","volume":"225","author":"Zhao","year":"2020","journal-title":"J. Proteomics"},{"issue":"18","key":"10.1016\/j.clinbiochem.2024.110776_b0615","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1002\/pmic.201500004","article-title":"Applications of targeted proteomics in systems biology and translational medicine","volume":"15","author":"Ebhardt","year":"2015","journal-title":"Proteomics"},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b0620","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/14789450.2017.1322904","article-title":"Clinical applications of quantitative proteomics using targeted and untargeted data-independent acquisition techniques","volume":"14","author":"Meyer","year":"2017","journal-title":"Expert Reviews in Proteomics."},{"issue":"11","key":"10.1016\/j.clinbiochem.2024.110776_b0625","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13112512","article-title":"Proteomics, personalized medicine and cancer","volume":"13","author":"Su","year":"2021","journal-title":"Cancers (basel)."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b0630","doi-asserted-by":"crossref","first-page":"5350","DOI":"10.3390\/ijms24065350","article-title":"Bottom-up proteomics: advancements in sample preparation","volume":"24","author":"Duong","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.clinbiochem.2024.110776_b0635","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11080554","article-title":"A robust method for sample preparation of gastrointestinal stromal tumour for LC\/MS untargeted metabolomics","volume":"11","author":"Macioszek","year":"2021","journal-title":"Metabolites"},{"key":"10.1016\/j.clinbiochem.2024.110776_b0640","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cca.2018.12.028","article-title":"Blood-based protein biomarkers in breast cancer","volume":"490","author":"Nunez","year":"2019","journal-title":"Clinica Chimica Acta: International Journal of Clinical Chemistry."},{"issue":"11","key":"10.1016\/j.clinbiochem.2024.110776_b0645","first-page":"6271","article-title":"Development and validation of a novel plasma protein signature for breast cancer diagnosis by using multiple reaction monitoring-based mass spectrometry","volume":"35","author":"Lee","year":"2015","journal-title":"Anticancer Res"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0650","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/prca.200800167","article-title":"Proteomic analysis of breast cancer tissue reveals upregulation of actin-remodeling proteins and its relevance to cancer invasiveness","volume":"3","author":"Kim","year":"2009","journal-title":"Proteomics Clin. Appl."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0655","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3858\/emm.2012.44.1.003","article-title":"Comparative profiling of plasma proteome from breast cancer patients reveals thrombospondin-1 and BRWD3 as serological biomarkers","volume":"44","author":"Suh","year":"2012","journal-title":"Exp. Mol. Med."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0660","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/prca.200780049","article-title":"Identification of circulating endorepellin LG3 fragment: Potential use as a serological biomarker for breast cancer","volume":"2","author":"Chang","year":"2008","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0665","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1471-2407-10-114","article-title":"Differential profiling of breast cancer plasma proteome by isotope-coded affinity tagging method reveals biotinidase as a breast cancer biomarker","volume":"10","author":"Kang","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clinbiochem.2024.110776_b0670","doi-asserted-by":"crossref","DOI":"10.1016\/j.prp.2021.153746","article-title":"The apolipoprotein C1 is involved in breast cancer progression via EMT and MAPK\/JNK pathway","volume":"229","author":"Zhang","year":"2022","journal-title":"Pathology - Research and Practice."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0675","doi-asserted-by":"crossref","DOI":"10.3390\/metabo8010019","article-title":"Carbonic anhydrases: role in pH control and cancer","volume":"8","author":"Mboge","year":"2018","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0680","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1475-2867-10-34","article-title":"Soluble L1CAM promotes breast cancer cell adhesion and migration in vitro, but not invasion","volume":"10","author":"Li","year":"2010","journal-title":"Cancer Cell Int."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b0685","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4048\/jbc.2019.22.e57","article-title":"A validation study of a multiple reaction monitoring-based proteomic assay to diagnose breast cancer","volume":"22","author":"Kim","year":"2019","journal-title":"J. Breast Cancer"},{"key":"10.1016\/j.clinbiochem.2024.110776_b0690","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fonc.2017.00014","article-title":"Label-free proteome analysis of plasma from patients with breast cancer: Stage-specific protein expression","volume":"7","author":"Lobo","year":"2017","journal-title":"Front. Oncol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b0695","doi-asserted-by":"crossref","DOI":"10.3390\/membranes12050532","article-title":"Role of lipoproteins in the pathophysiology of breast cancer","volume":"12","author":"Pandrangi","year":"2022","journal-title":"Membranes"},{"issue":"23","key":"10.1016\/j.clinbiochem.2024.110776_b0700","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.3390\/cancers15235565","article-title":"The role of apolipoproteins in the commonest cancers: a review","volume":"15","author":"Darwish","year":"2023","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0705","doi-asserted-by":"crossref","first-page":"31","DOI":"10.21037\/tcr-22-1882","article-title":"Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment","volume":"12","author":"Yang","year":"2023","journal-title":"Transl. Cancer Res."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0710","doi-asserted-by":"crossref","first-page":"e0149551","DOI":"10.1371\/journal.pone.0149551","article-title":"Unmasking heavily O-glycosylated serum proteins using perchloric acid: identification of serum proteoglycan 4 and protease c1 inhibitor as molecular indicators for screening of breast cancer","volume":"11","author":"Lee","year":"2016","journal-title":"PLoS One"},{"issue":"1\u20133","key":"10.1016\/j.clinbiochem.2024.110776_b0715","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/14789450.2024.2320158","article-title":"Deciphering a proteomic signature for the early detection of breast cancer from breast milk: the role of quantitative proteomics","volume":"21","author":"Whitham","year":"2024","journal-title":"Expert Rev. Proteomics"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0720","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12014-017-9179-4","article-title":"Evaluation of nipple aspirate fluid as a diagnostic tool for early detection of breast cancer","volume":"15","author":"Shaheed","year":"2018","journal-title":"Clin. Proteomics"},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b0725","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/proteomes10040036","article-title":"Mass spectrometry-based proteomics of human milk to identify differentially expressed proteins in women with breast cancer versus controls","volume":"10","author":"Aslebagh","year":"2022","journal-title":"Proteomes."},{"issue":"9\u201310","key":"10.1016\/j.clinbiochem.2024.110776_b0730","article-title":"Nipple aspirate fluid - a liquid biopsy for diagnosing breast health","volume":"11","author":"Shaheed","year":"2017","journal-title":"Proteomics Clin. Appl."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b0735","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/prca.201500016","article-title":"Identification of potential breast cancer markers in nipple discharge by protein profile analysis using two-dimensional nano-liquid chromatography\/nanoelectrospray ionization-mass spectrometry","volume":"10","author":"Kurono","year":"2016","journal-title":"Proteomics Clin. Appl."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0740","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.redox.2016.10.010","article-title":"Tumor cells have decreased ability to metabolize H(2)O(2): Implications for pharmacological ascorbate in cancer therapy","volume":"10","author":"Doskey","year":"2016","journal-title":"Redox Biol."},{"issue":"9","key":"10.1016\/j.clinbiochem.2024.110776_b0745","doi-asserted-by":"crossref","DOI":"10.3390\/cancers10090305","article-title":"Peroxiredoxin II regulates cancer stem cells and stemness-associated properties of cancers","volume":"10","author":"Chandimali","year":"2018","journal-title":"Cancers (basel)."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b0750","doi-asserted-by":"crossref","first-page":"377","DOI":"10.21873\/cgp.20143","article-title":"Comparative proteome analysis of breast cancer tissues highlights the importance of glycerol-3-phosphate dehydrogenase 1 and monoacylglycerol lipase in breast cancer metabolism","volume":"16","author":"Yoneten","year":"2019","journal-title":"Cancer Genomics Proteomics"},{"key":"10.1016\/j.clinbiochem.2024.110776_b0755","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jprot.2015.11.024","article-title":"Quantitative tissue proteomic investigation of invasive ductal carcinoma of breast with luminal B HER2 positive and HER2 enriched subtypes towards potential diagnostic and therapeutic biomarkers","volume":"132","author":"Pendharkar","year":"2016","journal-title":"J. Proteomics"},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110776_b0760","doi-asserted-by":"crossref","first-page":"e1700119","DOI":"10.1002\/prca.201700119","article-title":"A novel strategy to investigate tissue-secreted tumor microenvironmental proteins in serum toward development of breast cancer early diagnosis biomarker signature","volume":"13","author":"Pendharkar","year":"2019","journal-title":"Proteomics Clin. Appl."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0765","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s13273-018-0014-4","article-title":"Exosomes as diagnostic biomarkers in cancer","volume":"14","author":"Kim","year":"2018","journal-title":"Mol. Cell. Toxicol."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0770","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/s42003-019-0570-8","article-title":"Proteomic profiling of extracellular vesicles allows for human breast cancer subtyping","volume":"2","author":"Rontogianni","year":"2019","journal-title":"Communications Biology."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0775","doi-asserted-by":"crossref","first-page":"13572","DOI":"10.1038\/s41598-020-70393-4","article-title":"The proteomic analysis of breast cell line exosomes reveals disease patterns and potential biomarkers","volume":"10","author":"Risha","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.clinbiochem.2024.110776_b0780","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/14789450.2017.1285703","article-title":"The power of tears: how tear proteomics research could revolutionize the clinic","volume":"14","author":"Zhou","year":"2017","journal-title":"Expert Rev. Proteomics"},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b0785","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.3390\/app12062884","article-title":"Tears as the next diagnostic biofluid: a comparative study between ocular fluid and blood","volume":"12","author":"Ravishankar","year":"2022","journal-title":"Appl. Sci."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0790","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3892\/or.2012.1849","article-title":"Comparison of tear protein levels in breast cancer patients and healthy controls using a de novo proteomic approach","volume":"28","author":"B\u00f6hm","year":"2012","journal-title":"Oncol. Rep."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b0795","doi-asserted-by":"crossref","first-page":"e0267676","DOI":"10.1371\/journal.pone.0267676","article-title":"Using tears as a non-invasive source for early detection of breast cancer","volume":"17","author":"Daily","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0800","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nrc3893","article-title":"S100 proteins in cancer","volume":"15","author":"Bresnick","year":"2015","journal-title":"Nature Reviews in Cancer."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0805","doi-asserted-by":"crossref","first-page":"104","DOI":"10.30699\/ijp.14.2.104","article-title":"Clinical value of serum S100A8\/A9 and CA15-3 in the diagnosis of breast cancer","volume":"14","author":"Khorrami","year":"2019","journal-title":"Iran. J. Pathol."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0810","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2018.00496","article-title":"Clinical significance of elevated S100A8 expression in breast cancer patients","volume":"8","author":"Wang","year":"2018","journal-title":"Front. Oncol."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b0815","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1021\/acs.jproteome.0c00038","article-title":"Triple negative breast cancer detection using LC\u2013MS\/MS lipidomic profiling","volume":"19","author":"Eghlimi","year":"2020","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0820","article-title":"Subtypes of breast cancer","author":"Orrantia-Borunda","year":"2022","journal-title":"Breast Cancer [Internet]."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0825","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13058-023-01644-1","article-title":"Carbonic anhydrases reduce the acidity of the tumor microenvironment, promote immune infiltration, decelerate tumor growth, and improve survival in ErbB2\/HER2-enriched breast cancer","volume":"25","author":"Lee","year":"2023","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0830","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2407-9-16","article-title":"Identification of ATP synthase beta subunit (ATPB) on the cell surface as a non-small cell lung cancer (NSCLC) associated antigen","volume":"9","author":"Lu","year":"2009","journal-title":"BMC Cancer"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0835","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41389-022-00405-7","article-title":"Calreticulin enhances gastric cancer metastasis by dimethylating H3K9 in the E-cadherin promoter region mediating by G9a","volume":"11","author":"Wang","year":"2022","journal-title":"Oncogenesis."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b0840","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1373\/clinchem.2003.027425","article-title":"Identification by proteomic analysis of calreticulin as a marker for bladder cancer and evaluation of the diagnostic accuracy of its detection in urine","volume":"50","author":"Kageyama","year":"2004","journal-title":"Clin. Chem."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b0845","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00262-011-1146-8","article-title":"Calreticulin as a potential diagnostic biomarker for lung cancer","volume":"61","author":"Liu","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0850","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12885-016-2283-4","article-title":"Diagnostic values of serum cathepsin B and D in patients with nasopharyngeal carcinoma","volume":"16","author":"Tan","year":"2016","journal-title":"BMC Cancer"},{"issue":"25","key":"10.1016\/j.clinbiochem.2024.110776_b0855","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.9615","article-title":"Downregulation of HSP60 disrupts mitochondrial proteostasis to promote tumorigenesis and progression in clear cell renal cell carcinoma","volume":"7","author":"Tang","year":"2016","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0860","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1007\/s12032-013-0786-2","article-title":"Diagnostic and prognostic significance of peroxiredoxin 1 expression in human hepatocellular carcinoma","volume":"31","author":"Sun","year":"2013","journal-title":"Med. Oncol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b0865","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1177\/147323001003800510","article-title":"ADP-ribosylation factor guanine nucleotide-exchange factor 2 (ARFGEF2): a new potential biomarker in Huntington's disease","volume":"38","author":"Lovrecic","year":"2010","journal-title":"J. Int. Med. Res."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0870","article-title":"Unraveling proto-oncogene (ErbB2) expression in patients with carcinoma head of pancreas and chronic pancreatitis patients: a case-control study","volume":"16","author":"Mohanan","year":"2024","journal-title":"Cureus."},{"issue":"10","key":"10.1016\/j.clinbiochem.2024.110776_b0875","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1080\/09168451.2018.1484271","article-title":"The proliferation of colorectal cancer cells is suppressed by silencing of EIF3H","volume":"82","author":"Yu","year":"2018","journal-title":"Biosci. Biotech. Bioch."},{"issue":"16","key":"10.1016\/j.clinbiochem.2024.110776_b0880","doi-asserted-by":"crossref","first-page":"3221","DOI":"10.7150\/ijbs.49410","article-title":"Upregulated GRB7 promotes proliferation and tumorigenesis of bladder cancer via phospho-AKT pathway","volume":"16","author":"Zheng","year":"2020","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0885","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s13277-015-3834-z","article-title":"Carbonic anhydrase 1 is a promising biomarker for early detection of non-small cell lung cancer","volume":"37","author":"Wang","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0890","doi-asserted-by":"crossref","DOI":"10.5402\/2012\/768190","article-title":"Carbonic anhydrase I as a new plasma biomarker for prostate cancer","volume":"2012","author":"Takakura","year":"2012","journal-title":"ISRN Oncology."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b0895","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.kjms.2011.11.007","article-title":"Molecular markers associated with nonepithelial ovarian cancer in formalin-fixed, paraffin-embedded specimens by genome wide expression profiling","volume":"28","author":"Vui-Kee","year":"2012","journal-title":"Kaohsiung J. Med. Sci."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0900","doi-asserted-by":"crossref","first-page":"e30885","DOI":"10.1371\/journal.pone.0030885","article-title":"iTRAQ identification of candidate serum biomarkers associated with metastatic progression of human prostate cancer","volume":"7","author":"Rehman","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.clinbiochem.2024.110776_b0905","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/193052","article-title":"Separation and identification of HSP-associated protein complexes from pancreatic cancer cell lines using 2D CN\/SDS-PAGE coupled with mass spectrometry","volume":"2011","author":"Zhao","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"issue":"12","key":"10.1016\/j.clinbiochem.2024.110776_b0910","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1593\/neo.10780","article-title":"NHERF1\/EBP50 is a new marker in colorectal cancer","volume":"12","author":"Hayashi","year":"2010","journal-title":"Neoplasia"},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b0915","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s12033-015-9848-3","article-title":"Fine needle aspiration cytology: a tool to study NHERF1 expression as a potential marker of aggressiveness in lung cancer","volume":"57","author":"Mangia","year":"2015","journal-title":"Mol. Biotechnol."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0920","doi-asserted-by":"crossref","first-page":"18399","DOI":"10.1038\/s41598-019-54686-x","article-title":"Upregulation of tropomyosin alpha-4 chain in patients' saliva with oral squamous cell carcinoma as demonstrated by Phage display","volume":"9","author":"Faria","year":"2019","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0925","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12883-023-03058-0","article-title":"Overexpression of TPM4 is associated with worse prognosis and immune infiltration in patients with glioma","volume":"23","author":"Li","year":"2023","journal-title":"BMC Neurol."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b0930","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041140","article-title":"Glucose-regulated protein 78 is a potential serum and imaging marker for early detection of ovarian cancer","volume":"15","author":"Paris","year":"2023","journal-title":"Cancers (Basel)."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b0935","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/pmic.200300399","article-title":"A strategy for the comparative analysis of serum proteomes for the discovery of biomarkers for hepatocellular carcinoma","volume":"3","author":"Steel","year":"2003","journal-title":"Proteomics"},{"issue":"26","key":"10.1016\/j.clinbiochem.2024.110776_b0940","doi-asserted-by":"crossref","first-page":"8646","DOI":"10.3748\/wjg.v20.i26.8646","article-title":"Lipid levels in serum and cancerous tissues of colorectal cancer patients","volume":"20","author":"Zhang","year":"2014","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0945","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.mpa.0000250128.57026.b2","article-title":"Identification of potential markers for the detection of pancreatic cancer through comparative serum protein expression profiling","volume":"34","author":"Ehmann","year":"2007","journal-title":"Pancreas"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0950","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12014-018-9194-0","article-title":"Identification of serum proteins AHSG, FGA and APOA-I as diagnostic biomarkers for gastric cancer","volume":"15","author":"Shi","year":"2018","journal-title":"Clin. Proteomics"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b0955","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1477-5956-9-21","article-title":"Identification of Apo-A1 as a biomarker for early diagnosis of bladder transitional cell carcinoma","volume":"9","author":"Li","year":"2011","journal-title":"Proteome Sci."},{"issue":"12","key":"10.1016\/j.clinbiochem.2024.110776_b0960","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1074\/mcp.RA118.000734","article-title":"Evaluation of serum glycoprotein biomarker candidates for detection of esophageal adenocarcinoma and surveillance of Barrett's esophagus","volume":"17","author":"Shah","year":"2018","journal-title":"Mol. Cell. Proteomics"},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b0965","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.7150\/jca.28529","article-title":"Lower expression of gelsolin in colon cancer and its diagnostic value in colon cancer patients","volume":"10","author":"Chen","year":"2019","journal-title":"J. Cancer"},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b0970","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061534","article-title":"Systemic proteome alterations linked to early stage pancreatic cancer in diabetic patients","volume":"12","author":"Peng","year":"2020","journal-title":"Cancers (Basel)."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b0975","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12061569","article-title":"Circulating plasma gelsolin: a predictor of favorable clinical outcomes in head and neck cancer and sensitive biomarker for early disease diagnosis combined with soluble fas ligand","volume":"12","author":"Chiu","year":"2020","journal-title":"Cancers (Basel)."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b0980","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejso.2006.10.024","article-title":"Differential expression of manganese superoxide dismutase, copper\/zinc superoxide dismutase, and catalase in gastric adenocarcinoma and normal gastric mucosa","volume":"33","author":"Hwang","year":"2007","journal-title":"Eur. J. Surg. Oncol."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b0985","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1046\/j.1365-2133.2003.05303.x","article-title":"Oxidative stress in malignant melanoma and non-melanoma skin cancer","volume":"148","author":"Sander","year":"2003","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b0990","first-page":"330","article-title":"Antioxidant enzymes activities and plasma levels of oxidative stress markers in B-chronic lymphocytic leukemia patients","volume":"15","author":"Zelen","year":"2010","journal-title":"J. B.U.ON."},{"key":"10.1016\/j.clinbiochem.2024.110776_b0995","article-title":"The role of heat shock protein 40 in carcinogenesis and biology of colorectal cancer","volume":"28","author":"Asgharzadeh","year":"2022","journal-title":"Curr. Pharm. Des."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b1000","first-page":"2941","article-title":"EphA2-enriched exosomes promote cell migration and are a potential diagnostic serum marker in pancreatic cancer","volume":"22","author":"Wei","year":"2020","journal-title":"Mol. Med. Rep."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b1005","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1349-7006.2005.00007.x","article-title":"EPHA2\/EFNA1 expression in human gastric cancer","volume":"96","author":"Nakamura","year":"2005","journal-title":"Cancer Sci."},{"issue":"6","key":"10.1016\/j.clinbiochem.2024.110776_b1010","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1136\/jim-2020-001744","article-title":"Utility of serum neuropilin-1 and angiopoietin-2 as markers of hepatocellular carcinoma","volume":"69","author":"Abdel Ghafar","year":"2021","journal-title":"J. Invest. Med."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1015","article-title":"Atherosclerosis-related biomarker PABPC1 predicts pan-cancer events. stroke and Vascular","author":"Lin","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.clinbiochem.2024.110776_b1020","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/CEJ.0000000000000788","article-title":"Cytoplasmic poly(A)-binding protein 1 as a biomarker to assist early diagnosis and prognosis of esophageal squamous cell carcinoma in endoscopic biopsy fragments","volume":"32","author":"Li","year":"2023","journal-title":"European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation (ECP)."},{"issue":"1\u20132","key":"10.1016\/j.clinbiochem.2024.110776_b1025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neurol.2023.04.002","article-title":"ADAM10 as a biomarker for Alzheimer's disease: a systematic review","volume":"180","author":"Oliveira Monteiro","year":"2024","journal-title":"Rev. Neurol."},{"issue":"7559","key":"10.1016\/j.clinbiochem.2024.110776_b1030","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature14581","article-title":"Glypican-1 identifies cancer exosomes and detects early pancreatic cancer","volume":"523","author":"Melo","year":"2015","journal-title":"Nature"},{"issue":"32","key":"10.1016\/j.clinbiochem.2024.110776_b1035","doi-asserted-by":"crossref","first-page":"22359","DOI":"10.18632\/oncotarget.25009","article-title":"Development of a reliable assay to measure glypican-1 in plasma and serum reveals circulating glypican-1 as a novel prostate cancer biomarker","volume":"9","author":"Levin","year":"2018","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b1040","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/cncr.10309","article-title":"Diagnostic utility of Glut-1 and CA 15\u20133 in discriminating adenocarcinoma from hepatocellular carcinoma in liver tumors biopsied by fine-needle aspiration","volume":"96","author":"Zimmerman","year":"2002","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b1045","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/MPA.0b013e318201c935","article-title":"GLUT-1 expression in pancreatic neoplasia: implications in pathogenesis, diagnosis, and prognosis","volume":"40","author":"Basturk","year":"2011","journal-title":"Pancreas"},{"issue":"16","key":"10.1016\/j.clinbiochem.2024.110776_b1050","doi-asserted-by":"crossref","first-page":"380","DOI":"10.21037\/atm.2019.07.59","article-title":"Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer","volume":"7","author":"Yi","year":"2019","journal-title":"Annals of Translational Medicine."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1055","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.01436","article-title":"Apolipoprotein C1 (APOC1): A novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma","volume":"10","author":"Cui","year":"2020","journal-title":"Front. Oncol."},{"issue":"16","key":"10.1016\/j.clinbiochem.2024.110776_b1060","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1111\/jcmm.17813","article-title":"GPD1L inhibits renal cell carcinoma progression by regulating PINK1\/Parkin-mediated mitophagy","volume":"27","author":"Liu","year":"2023","journal-title":"J. Cell Mol. Med."},{"issue":"10","key":"10.1016\/j.clinbiochem.2024.110776_b1065","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1111\/jog.14070","article-title":"Effect of monoacylglycerol lipase on the tumor growth in endometrial cancer","volume":"45","author":"Li","year":"2019","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1070","doi-asserted-by":"crossref","first-page":"11246","DOI":"10.1038\/ncomms11246","article-title":"Highly variable cancer subpopulations that exhibit enhanced transcriptome variability and metastatic fitness","volume":"7","author":"Nguyen","year":"2016","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b1075","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4161\/cam.21489","article-title":"Molecular mechanisms of cancer cell-cell interactions: Cell-cell adhesion-dependent signaling in the tumor microenvironment","volume":"6","author":"Brady-Kalnay","year":"2012","journal-title":"Cell Adh. Migr."},{"issue":"10","key":"10.1016\/j.clinbiochem.2024.110776_b1080","doi-asserted-by":"crossref","first-page":"e13696","DOI":"10.1371\/journal.pone.0013696","article-title":"A comparative analysis of gene-expression data of multiple cancer types","volume":"5","author":"Xu","year":"2010","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.clinbiochem.2024.110776_b1085","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13163949","article-title":"The pathogenic role of PI3K\/AKT pathway in cancer onset and drug resistance: an updated review","volume":"13","author":"Rascio","year":"2021","journal-title":"Cancers (basel)."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b1090","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2174\/0929867321666141106124315","article-title":"Targeting the NF\u03baB signaling pathways for breast cancer prevention and therapy","volume":"22","author":"Wang","year":"2015","journal-title":"Curr. Med. Chem."},{"issue":"16","key":"10.1016\/j.clinbiochem.2024.110776_b1095","doi-asserted-by":"crossref","first-page":"7032","DOI":"10.1002\/cam4.2587","article-title":"Apolipoproteins and cancer","volume":"8","author":"Ren","year":"2019","journal-title":"Cancer Med."},{"issue":"9\u201310","key":"10.1016\/j.clinbiochem.2024.110776_b1100","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1177\/1947601913507951","article-title":"Role of p38 MAP kinase signal transduction in solid tumors","volume":"4","author":"Koul","year":"2013","journal-title":"Genes Cancer."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b1105","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3390\/livers4010011","article-title":"Functions and therapeutic use of heat shock proteins in hepatocellular carcinoma","volume":"4","author":"Paul","year":"2024","journal-title":"Livers."},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b1110","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3350\/cmh.2022.0425","article-title":"Neuropilins as potential biomarkers in hepatocellular carcinoma: a systematic review of basic and clinical implications","volume":"29","author":"Fern\u00e1ndez-Palanca","year":"2023","journal-title":"Clin. Mol. Hepatol."},{"issue":"8","key":"10.1016\/j.clinbiochem.2024.110776_b1115","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1007\/s00432-021-03635-1","article-title":"Soluble neuropilin-1 is an independent marker of poor prognosis in early breast cancer","volume":"147","author":"Rachner","year":"2021","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.clinbiochem.2024.110776_b1120","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100569","article-title":"An inflection point in cancer protein biomarkers: what was and what's next","volume":"22","author":"Barker","year":"2023","journal-title":"Mol. Cell. Proteomics"},{"issue":"8","key":"10.1016\/j.clinbiochem.2024.110776_b1125","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/clinchem\/48.8.1296","article-title":"Proteomics and bioinformatics approaches for identification of serum biomarkers to detect breast cancer","volume":"48","author":"Li","year":"2002","journal-title":"Clin. Chem."},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b1130","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.surge.2014.12.003","article-title":"Clinical proteomics and breast cancer","volume":"13","author":"Zeidan","year":"2015","journal-title":"Surgeon"},{"key":"10.1016\/j.clinbiochem.2024.110776_b1135","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/260348","article-title":"Proteomic approaches in biomarker discovery: new perspectives in cancer diagnostics","volume":"2014","author":"Hudler","year":"2014","journal-title":"Sci. World J."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1140","unstructured":"National Comprehensive Cancer Network Guidelines. [Available from: https:\/\/www.nccn.org\/guidelines\/category_1."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1145","unstructured":"American Society of Clinical Oncology. Cancer care initiatives [Available from: https:\/\/society.asco.org\/news-initiatives\/current-initiatives\/cancer-care-initiatives."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1150","unstructured":"U.S. Food and Drug Administration. Biomarkers at FDA [Available from: https:\/\/www.fda.gov\/science-research\/about-science-research-fda\/biomarkers-fda."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1155","unstructured":"National Cancer Institute's Early Detection Research Network. About EDRN [Available from: https:\/\/edrn.nci.nih.gov\/about-edrn\/mission-and-structure\/."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1160","unstructured":"Foundation for the National Institutes of Health. Biomarker consortium [Available from: https:\/\/fnih.org\/our-programs\/biomarkers-consortium\/."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1165","unstructured":"National Cancer Institure Division of Cancer Prevention. Consortium for imaging and biomarkers [Available from: https:\/\/prevention.cancer.gov\/major-programs\/consortium-imaging-and-biomarkers-cib."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1170","article-title":"Advancements and applications of single-cell multi-omics techniques in cancer research: unveiling heterogeneity and paving the way for precision therapeutics","volume":"37","author":"Liang","year":"2024","journal-title":"Biochem. Biophys. Rep."},{"issue":"16","key":"10.1016\/j.clinbiochem.2024.110776_b1175","doi-asserted-by":"crossref","first-page":"12690","DOI":"10.3390\/ijms241612690","article-title":"Omics technologies improving breast cancer research and diagnostics","volume":"24","author":"Orsini","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1180","doi-asserted-by":"crossref","DOI":"10.1177\/1177932219899051","article-title":"Multi-omics data integration, interpretation, and its application","volume":"14","author":"Subramanian","year":"2020","journal-title":"Bioinf. Biol. Insights"},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b1185","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/s41571-018-0135-7","article-title":"Clinical potential of mass spectrometry-based proteogenomics","volume":"16","author":"Zhang","year":"2019","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2020.103991","article-title":"Identification of blood protein biomarkers for breast cancer staging by integrative transcriptome and proteome analyses","volume":"230","author":"Yao","year":"2021","journal-title":"J. Proteomics"},{"issue":"2","key":"10.1016\/j.clinbiochem.2024.110776_b1195","first-page":"317","article-title":"A review on neural networks approach on classifying cancers","volume":"9","author":"Mahmood","year":"2020","journal-title":"IAES International Journal of Artificial Intelligence."},{"issue":"9","key":"10.1016\/j.clinbiochem.2024.110776_b1200","article-title":"Genetic algorithm based adaptive receiver for MC-CDMA system with variation in mutation operator","volume":"14","author":"Ali","year":"2016","journal-title":"International Journal of Computer Science and Information Security (IJCSIS)"},{"key":"10.1016\/j.clinbiochem.2024.110776_b1205","doi-asserted-by":"crossref","unstructured":"C. Nguyen, Y. Wang, N.H. Nguyen. Random forest classifier combined with feature selection for breast cancer diagnosis and prognostic. 2013.","DOI":"10.4236\/jbise.2013.65070"},{"issue":"5","key":"10.1016\/j.clinbiochem.2024.110776_b1210","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1089\/omi.2020.0001","article-title":"New machine learning applications to accelerate personalized medicine in breast cancer: Rise of the support vector machines","volume":"24","author":"Ozer","year":"2020","journal-title":"OMICS"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b1215","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/03772063.2019.1583610","article-title":"Sliding window based support vector machine system for classification of breast cancer using histopathological microscopic images","volume":"68","author":"Alqudah","year":"2022","journal-title":"IETE J. Res."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1220","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s40846-017-0321-6","article-title":"An automatic computer-aided diagnosis system for breast cancer in digital mammograms via deep belief network","volume":"38","author":"Al-Antari","year":"2018","journal-title":"Journal of Medical and Biological Engineering."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1225","doi-asserted-by":"crossref","first-page":"150360","DOI":"10.1109\/ACCESS.2020.3016715","article-title":"Prediction of breast cancer, comparative review of machine learning techniques, and their analysis","volume":"8","author":"Fatima","year":"2020","journal-title":"IEEE Access"},{"issue":"4","key":"10.1016\/j.clinbiochem.2024.110776_b1230","doi-asserted-by":"crossref","first-page":"4879","DOI":"10.35940\/ijrte.D8292.118419","article-title":"Breast cancer prediction using machine learning","volume":"8","author":"Sivapriya","year":"2019","journal-title":"International Journal of Recent Technology and Engineering (IJRTE)."},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b1235","doi-asserted-by":"crossref","first-page":"49","DOI":"10.33545\/26633582.2022.v4.i1a.68","article-title":"Breast cancer detection based on thermographic images using machine learning and deep learning algorithms","volume":"4","author":"Allugunti","year":"2022","journal-title":"International Journal of Engineering in Computer Science."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12859-019-2823-4","article-title":"Deep convolutional neural networks for mammography: advances, challenges and applications","volume":"20","author":"Abdelhafiz","year":"2019","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1245","doi-asserted-by":"crossref","first-page":"8017496","DOI":"10.1155\/2020\/8017496","article-title":"Cloud-based breast cancer prediction empowered with soft computing approaches","volume":"2020","author":"Khan","year":"2020","journal-title":"Journal of Healthcare Engineering."},{"issue":"19","key":"10.1016\/j.clinbiochem.2024.110776_b1250","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.3390\/diagnostics13193113","article-title":"Breast cancer detection and prevention using machine learning","volume":"13","author":"Khalid","year":"2023","journal-title":"Diagnostics."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1255","doi-asserted-by":"crossref","unstructured":"E.J. Sweetlin, S. Saudia editors. A review of machine learning algorithms on different breast cancer datasets. Big Data, Machine Learning, and Applications; 2024 2024\/\/; Singapore: Springer Nature Singapore.","DOI":"10.1007\/978-981-99-3481-2_51"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b1260","first-page":"2299093","article-title":"Machine-learning methods in detecting breast cancer and related therapeutic issues: a review","volume":"12","author":"Jafari","year":"2024","journal-title":"Computer Methods in Biomechanics and Biomedical Engineering: Imaging & Visualization."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1265","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2023.104955","article-title":"High-throughput proteomics of breast cancer subtypes: biological characterization and multiple candidate biomarker panels to patients' stratification","volume":"285","author":"Azevedo","year":"2023","journal-title":"J. Proteomics"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b1270","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s43856-022-00199-0","article-title":"Artificial intelligence and machine learning in cancer imaging","volume":"2","author":"Koh","year":"2022","journal-title":"Communications Medicine."},{"key":"10.1016\/j.clinbiochem.2024.110776_b1275","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.600557","article-title":"Artificial intelligence in medical imaging of the breast","volume":"11","author":"Lei","year":"2021","journal-title":"Front. Oncol."},{"issue":"10","key":"10.1016\/j.clinbiochem.2024.110776_b1280","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.eng.2021.04.024","article-title":"The fibrillar matrix: Novel avenues for breast cancer detection and treatment","volume":"7","author":"Rezk","year":"2021","journal-title":"Engineering"},{"issue":"1","key":"10.1016\/j.clinbiochem.2024.110776_b1285","doi-asserted-by":"crossref","first-page":"7316","DOI":"10.1038\/s41598-023-34588-9","article-title":"New, fast and cheap prediction tests for BRCA1 gene mutations identification in clinical samples","volume":"13","author":"Gajda-Walczak","year":"2023","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.clinbiochem.2024.110776_b1290","article-title":"Diagnosis and prognosis of breast cancer by high-performance serum metabolic fingerprints","volume":"119","author":"Huang","year":"2022","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024000705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912024000705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T09:32:08Z","timestamp":1719307928000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912024000705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":258,"alternative-id":["S0009912024000705"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110776","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring novel protein-based biomarkers for advancing breast cancer diagnosis: A review","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2024.110776","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110776"}}